Asosiy kontentga oʻtish
Maqola

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

Changsong QiState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute, Beijing, China. [email protected]Chang LiuPeking University Cancer HospitalJifang GongPeking University Cancer HospitalDan LiuPeking University Cancer HospitalXicheng WangPeking University Cancer HospitalPanpan ZhangPeking University Cancer HospitalYanru QinDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaSai GePeking University Cancer HospitalMiao ZhangPeking University Cancer HospitalZhi PengPeking University Cancer HospitalJun ZhouKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaZhihao LüPeking University Cancer HospitalMing LuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaYanshuo CaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaJiajia YuanPeking University Cancer HospitalYakun WangRegend Therapeutics (China)Zhenghang WangPeking University Cancer HospitalRan XueKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaXiaohui PengCARsgen Therapeutics Co., Ltd., Shanghai, ChinaYumeng WangCARsgen Therapeutics Co., Ltd., Shanghai, ChinaDaijing YuanCARsgen Therapeutics Co., Ltd., Shanghai, ChinaJian LiState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaXiaotian ZhangState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China. [email protected]Lin ShenState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China. [email protected]
2024en
ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba